Skip to main content
Caplight Logo









Biolinq

Biolinq

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.biolinq.com/

Last Round

Series C

Apr 22, 2025

Est. Valuation

$405M

Total Funding Raised

$214.75M

Company Overview

Biolinq is a healthcare technology company that develops a wearable biosensor platform for continuous monitoring of metabolic health, including glucose, ketones, and lactate.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Biotechnology

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

continuous glucose monitorCGMneedle-free glucose sensorintradermal sensorbiowearablemetabolic healthwearable biosensornon-invasive monitoringglucose patchautonomous health trackingdiabetes managementhealth IoTdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolinq Comparables

Compare Biolinq with similar companies based on industry and business-model similarity.

Biolinq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlucoModicum
83%
Allez Health
81%
RSP Systems A/S
80%

Biolinq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 22, 2025
VC RoundApr 4, 2024
Series BNov 2, 2021
Series A ExtensionMar 28, 2019
Series ANov 27, 2017

Key People

Founding team and executive leadership

Jared Tangney

Co-Founder, President & CTO

Founding Team

Rich Yang

CEO

Executive Team

Biolinq Investors

Notable investors and investment history

Biolinq investors
InvestorRounds
Senvest CapitalSeries B
Grey Sky Venture PartnersSeries A
LifeSci Venture PartnersSeries C, Series A, Series A Extension
Aphelion CapitalSeries C, VC Round, Series B, Series A Extension
Able PartnersSeries B
Senvest ManagementVC Round, Series B
Longevity Vision FundSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2025

    Job posting discloses that Biolinq is a clinical stage medical device company, indicating its biosensor platform is undergoing clinical trials.

  • Sep 23, 2025

    Developing minimally invasive biosensors for continuous skin-worn sensing.

Biolinq Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biolinq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biolinq's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range133
Year Founded2012
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?